Cafepharma Today

January 30 2025 - Novo Nordisk commences fresh trials for CagriSema
Novo Nordisk commences fresh trials for CagriSema
Express Scripts becomes latest PBM to follow in Mark Cuban's footsteps
With efficacy assured, Merck halts another trial of blockbuster-to-be Winrevair
Sanofi plans €5 billion buyback, sees higher profit growth
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Endo says 78 percent of Indevus shares tendered
Yahoo/AP
Monday, February 23, 2009 - 5:39pm
tags:
Endo, Indevus, buyouts
Sepracor Near 200-day MA
Yahoo/Zacks.com
Monday, February 23, 2009 - 5:38pm
tags:
Sepracor
[video]Generic Drugmakers Outperforming
Yahoo/CNBC
Monday, February 23, 2009 - 5:37pm
tags:
generics, Teva Pharmaceuticals
Walking The Vytorin Tightrope
Forbes
Monday, February 23, 2009 - 5:09pm
tags:
Vytorin, Merck, Schering Plough
Pfizer cuts severance deals for executives
The Day, CT
Monday, February 23, 2009 - 4:56pm
tags:
Pfizer, severance
Genzyme Playing Defense
Motley Fool
Monday, February 23, 2009 - 4:47pm
tags:
Genzyme, AstraZeneca, Amicus Therapeutics
Why Kindler Wants to Make Pfizer More Like J&J
WSJ Online
Monday, February 23, 2009 - 4:43pm
tags:
Pfizer, JNJ, Jeff Kindler
Spicing Up the Biotech Portfolio with Microcaps CuraGen and Curis
Seeking Alpha
Monday, February 23, 2009 - 10:46am
tags:
biotech, Curis, CuraGen, cancer
CV Therapeutics To Astellas: No Thanks
Forbes
Monday, February 23, 2009 - 10:43am
tags:
CV Therapeutics, buyouts, Astellas
Booming biz raises questions about vax legal shield
Fierce Biotech
Monday, February 23, 2009 - 10:41am
tags:
vaccines
Endo, Penwest settle patent dispute with Actavis
Yahoo/AP
Monday, February 23, 2009 - 10:33am
tags:
Endo, Penwest, patents, Actavis, Opana ER
Five Buy-Rated Drug Stocks to Watch
TheStreet.com
Monday, February 23, 2009 - 10:32am
tags:
JNJ, Novartis, Abbott Laboratories, Wyeth, Bristol-Myers Squibb
Merck girds to battle Teva's generic Singulair
Reuters
Monday, February 23, 2009 - 9:40am
tags:
Merck, Teva Pharmaceuticals, Singulair, generics
Washington Post’s Stock Tip for Chief Justice Roberts: Sell Pfizer
WSJ Online
Monday, February 23, 2009 - 9:35am
tags:
Pfizer
Another Drug Makes It to Europe First: Lilly’s Blood Thinner Prasugrel
WSJ Online
Monday, February 23, 2009 - 9:34am
tags:
Eli Lilly, Europe, Prasugrel
Biotech FDA and Clinical Trial Calendar Update
Seeking Alpha
Monday, February 23, 2009 - 8:50am
tags:
biotech, FDA, drug trials
AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression
Yahoo
Monday, February 23, 2009 - 8:43am
tags:
AstraZeneca, Seroquel, bipolar disorder
Cordex files amended SPA for tachycardia drug to FDA
Pharmaceutical Business Review
Monday, February 23, 2009 - 7:39am
tags:
FDA, Cordex Pharma, tachycardia
Astellas Pharma to continue pursuing buyout of CV Therapeutics following latest rejection
Yahoo/AP
Monday, February 23, 2009 - 7:37am
tags:
Astellas, buyouts, CV Therapeutics
Neurobiological Technologies Could Go the Way of Avigen
Seeking Alpha
Monday, February 23, 2009 - 7:36am
tags:
Neurobiological Technologies, Avigen, biotech

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline

Latest Jobs

Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Tuscaloosa, Alabama
Eli Lilly and Company
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, US
Lundbeck
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, 17602
Lundbeck
Account Executive - Women's Health - W Palm Beach
Salt Lake City, Utah, 84101
Myriad Genetics
Pharmaceutical Sales Rep- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Psychiatry Account Manager - Atlanta East / Augusta, GA
Augusta, Georgia, US
Lundbeck
Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Billings, MT
Billings, Montana, US
Lundbeck
Neuroscience Account Manager - Indianapolis, IN
Indianapolis, Indiana, US
Lundbeck
Hybrid Pharmaceutical Sales Representative- EST/CST
Kansas City, Kansas, 66101
Amplity Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information